A new mRNA vaccine, tested alongside immunotherapy, has helped reduce the risk of melanoma returning or spreading in patients who have undergone surgery. By using information from a patient's own tumour to train the immune system, the treatment offers a new approach to preventing cancer relapse - with trials now expanding to other types of the disease.

About the AI positivity score